Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)
Authors:
- J. RenardJRJ. Renard
- H.M. PinedoHPH.M. Pinedo
- F. CavalliFCF. Cavalli
- J. VermorkenJVJ. Vermorken
- C. SessaCSC. Sessa
- R. AbeleRAR. Abele
- M. ClavelMCM. Clavel
- S. MonfardiniSMS. Monfardini
- 1 February 1988
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (2) , 255-262
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1988
- Phase II study of iproplatin in advanced ovarian carcinoma.Journal of Clinical Oncology, 1988
- A phase II study of carboplatin in advanced or metastatic stomach cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neckEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase I study of carboplatin given on a five-day intravenous schedule.Journal of Clinical Oncology, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Simple Regression Methods for Survival Time StudiesJournal of the American Statistical Association, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945